120 related articles for article (PubMed ID: 34989166)
1. Effective Genome Editing Using CRISPR-Cas9 Nanoflowers.
Zhang C; Ren H; Liu G; Li J; Wang X; Zhang Y
Adv Healthc Mater; 2022 May; 11(10):e2102365. PubMed ID: 34989166
[TBL] [Abstract][Full Text] [Related]
2. CRISPR/Cas9 and Chlorophyll Coordination Micelles for Cancer Treatment by Genome Editing and Photodynamic Therapy.
Zhang C; Wang X; Liu G; Ren H; Liu J; Jiang Z; Zhang Y
Small; 2023 Apr; 19(17):e2206981. PubMed ID: 36693779
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-responsive release of Cas9/sgRNA from DNA nanoflower for cytosolic protein delivery and enhanced genome editing.
Shi J; Yang X; Li Y; Wang D; Liu W; Zhang Z; Liu J; Zhang K
Biomaterials; 2020 Oct; 256():120221. PubMed ID: 32738651
[TBL] [Abstract][Full Text] [Related]
4. Polymeric micellar nanoparticles for effective CRISPR/Cas9 genome editing in cancer.
Li Y; Li C; Yan J; Liao Y; Qin C; Wang L; Huang Y; Yang C; Wang J; Ding X; Yang YY; Yuan P
Biomaterials; 2024 Sep; 309():122573. PubMed ID: 38677222
[TBL] [Abstract][Full Text] [Related]
5. Spatiotemporal Delivery of CRISPR/Cas9 Genome Editing Machinery Using Stimuli-Responsive Vehicles.
Cai W; Luo T; Mao L; Wang M
Angew Chem Int Ed Engl; 2021 Apr; 60(16):8596-8606. PubMed ID: 32385892
[TBL] [Abstract][Full Text] [Related]
6. Coassembly of nucleus-targeting gold nanoclusters with CRISPR/Cas9 for simultaneous bioimaging and therapeutic genome editing.
Tao Y; Yi K; Hu H; Shao D; Li M
J Mater Chem B; 2021 Jan; 9(1):94-100. PubMed ID: 33220661
[TBL] [Abstract][Full Text] [Related]
7. Co-delivery of Sorafenib and CRISPR/Cas9 Based on Targeted Core-Shell Hollow Mesoporous Organosilica Nanoparticles for Synergistic HCC Therapy.
Zhang BC; Luo BY; Zou JJ; Wu PY; Jiang JL; Le JQ; Zhao RR; Chen L; Shao JW
ACS Appl Mater Interfaces; 2020 Dec; 12(51):57362-57372. PubMed ID: 33301289
[TBL] [Abstract][Full Text] [Related]
8. Ultra-efficient delivery of CRISPR/Cas9 using ionic liquid conjugated polymers for genome editing-based tumor therapy.
Huang Z; Yang T; Yu J; Gao Y; Weng Y; Huang Y; Li S
Biomater Sci; 2024 Mar; 12(7):1716-1725. PubMed ID: 38344762
[TBL] [Abstract][Full Text] [Related]
9. Rationally designed nanoparticle delivery of Cas9 ribonucleoprotein for effective gene editing.
Chae SY; Jeong E; Kang S; Yim Y; Kim JS; Min DH
J Control Release; 2022 May; 345():108-119. PubMed ID: 35247491
[TBL] [Abstract][Full Text] [Related]
10. A CRISPR/Cas9 based polymeric nanoparticles to treat/inhibit microbial infections.
Verma R; Sahu R; Singh DD; Egbo TE
Semin Cell Dev Biol; 2019 Dec; 96():44-52. PubMed ID: 30986568
[TBL] [Abstract][Full Text] [Related]
11. Direct Cytosolic Delivery of CRISPR/Cas9-Ribonucleoprotein for Efficient Gene Editing.
Mout R; Ray M; Yesilbag Tonga G; Lee YW; Tay T; Sasaki K; Rotello VM
ACS Nano; 2017 Mar; 11(3):2452-2458. PubMed ID: 28129503
[TBL] [Abstract][Full Text] [Related]
12. Cationic Polymer-Mediated CRISPR/Cas9 Plasmid Delivery for Genome Editing.
Zhang Z; Wan T; Chen Y; Chen Y; Sun H; Cao T; Songyang Z; Tang G; Wu C; Ping Y; Xu FJ; Huang J
Macromol Rapid Commun; 2019 Mar; 40(5):e1800068. PubMed ID: 29708298
[TBL] [Abstract][Full Text] [Related]
13. Genome editing of mutant KRAS through supramolecular polymer-mediated delivery of Cas9 ribonucleoprotein for colorectal cancer therapy.
Wan T; Chen Y; Pan Q; Xu X; Kang Y; Gao X; Huang F; Wu C; Ping Y
J Control Release; 2020 Jun; 322():236-247. PubMed ID: 32169537
[TBL] [Abstract][Full Text] [Related]
14. Delivery of CRISPR/Cas9 Plasmid DNA by Hyperbranched Polymeric Nanoparticles Enables Efficient Gene Editing.
Xiu K; Saunders L; Wen L; Ruan J; Dong R; Song J; Yang D; Zhang J; Xu J; Chen YE; Ma PX
Cells; 2022 Dec; 12(1):. PubMed ID: 36611948
[TBL] [Abstract][Full Text] [Related]
15. Optical Control of a CRISPR/Cas9 System for Gene Editing by Using Photolabile crRNA.
Zhang Y; Ling X; Su X; Zhang S; Wang J; Zhang P; Feng W; Zhu YY; Liu T; Tang X
Angew Chem Int Ed Engl; 2020 Nov; 59(47):20895-20899. PubMed ID: 33448579
[TBL] [Abstract][Full Text] [Related]
16. Near-infrared optogenetic engineering of photothermal nanoCRISPR for programmable genome editing.
Chen X; Chen Y; Xin H; Wan T; Ping Y
Proc Natl Acad Sci U S A; 2020 Feb; 117(5):2395-2405. PubMed ID: 31941712
[TBL] [Abstract][Full Text] [Related]
17. Integrating Combinatorial Lipid Nanoparticle and Chemically Modified Protein for Intracellular Delivery and Genome Editing.
Chang J; Chen X; Glass Z; Gao F; Mao L; Wang M; Xu Q
Acc Chem Res; 2019 Mar; 52(3):665-675. PubMed ID: 30586281
[TBL] [Abstract][Full Text] [Related]
18. Autonomous Feedback-Driven Engineered DNAzyme-Coated Trojan Horse-like Nanocapsules for On-Demand CRISPR/Cas9 Delivery.
Tang X; Chen Y; Wang B; Luo D; Wang J; He Y; Feng L; Xu Y; Xie S; Chen M; Chang K
ACS Nano; 2024 May; 18(21):13950-13965. PubMed ID: 38751197
[TBL] [Abstract][Full Text] [Related]
19. Key considerations in designing CRISPR/Cas9-carrying nanoparticles for therapeutic genome editing.
Xu Y; Liu R; Dai Z
Nanoscale; 2020 Oct; 12(41):21001-21014. PubMed ID: 33078813
[TBL] [Abstract][Full Text] [Related]
20. A simple, quick, and efficient CRISPR/Cas9 genome editing method for human induced pluripotent stem cells.
Geng BC; Choi KH; Wang SZ; Chen P; Pan XD; Dong NG; Ko JK; Zhu H
Acta Pharmacol Sin; 2020 Nov; 41(11):1427-1432. PubMed ID: 32555510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
